Tandem Diabetes Care, Inc. Form 8-K Filing

This Form 8-K filing by Tandem Diabetes Care, Inc. reports on actions taken at the 2026 Annual Meeting of Stockholders held on May 20, 2026. Key approvals include amendments to the company's Amended and Restated Certificate of Incorporation to allow for director removal with or without cause and to limit officer liability to the maximum extent permitted by law. These amendments were subsequently filed with the State of Delaware on May 21, 2026. Additionally, stockholders approved amendments to the 2023 Long-Term Incentive Plan, increasing the authorized shares for issuance by 3,260,000. The filing also details the results of director elections, advisory vote on executive compensation, and the ratification of Ernst & Young LLP as the independent registered public accounting firm.